| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |